Bromsulphalein Excretion in Rats Treated with p-Dimethylaminoazobenzene
Author Information
Author(s): J. S. Howell
Primary Institution: University of Birmingham
Hypothesis
The study aimed to determine if there are functional differences in liver function between rats treated with p-dimethylaminoazobenzene with and without copper acetate.
Conclusion
The BSP excretion test results were normal in many rats with liver tumors, indicating that liver function can remain intact despite significant liver damage.
Supporting Evidence
- The BSP test results were normal in many rats with liver tumors, indicating a disconnect between liver damage and function.
- Normal BSP excretion was observed even in the presence of severe liver damage and cirrhosis.
- Statistical analysis showed significant differences in liver weight between groups with normal and abnormal BSP excretion.
Takeaway
The study found that even when rats had liver tumors, their ability to excrete a dye used to test liver function was often normal, which is surprising.
Methodology
Seventy albino rats were treated with various diets and tested for liver function using the bromsulphalein excretion test over a period of 15 months.
Limitations
The BSP test did not reveal differences between the treatment groups and was not effective in assessing liver function in pre-neoplastic stages.
Participant Demographics
Seventy albino rats of a heterozygous strain, divided into groups with equal numbers of males and females.
Statistical Information
P-Value
0.02 > P > 0.01
Statistical Significance
0.02 > P > 0.01
Want to read the original?
Access the complete publication on the publisher's website